Testing effectiveness (Phase 2)UnknownNCT06153368
What this trial is testing
Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC
Who this might be right for
Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Showing 20 of 0 results